Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

Documenti analoghi

• Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies
  di: Alexandra A. J. Sillé, et al.
  Pubblicazione: (2026)
• Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers
  di: Marella Cornelia Elizabeth van Ruissen, et al.
  Pubblicazione: (2025)
• Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers
  di: Lisanne K. A. Neijenhuis, et al.
  Pubblicazione: (2026)
• Proof of Pharmacology, Safety, and Pharmacokinetics of the Novel TRPA1 Antagonist BI 1839100: A Randomized, Placebo‐Controlled, Parallel Group, First‐In‐Human Study in Healthy Male Participants
  di: Marella C. E. van Ruissen, et al.
  Pubblicazione: (2025)
• Clinical Validation of Imaging Biomarkers in Mycosis Fungoides
  di: Selinde S. Wind, et al.
  Pubblicazione: (2026)